The personalized medicine market is rapidly transforming the healthcare landscape by enabling tailored treatment approaches based on individual genetic profiles, lifestyle, and environmental factors. This shift from a one-size-fits-all model to precision-based care is improving treatment outcomes and reducing adverse effects. According to insights from Straits Research, advancements in...

"According to the latest report published by Data Bridge Market Research, the Post-CDK4/6 Treatment Line Oncology Drugs Market  CAGR ValueThe global post-CDK4/6 treatment line oncology drugs market size was valued at USD 3.53 billion in 2025 and is expected to reach USD 10.06 billion by 2033, at a CAGR of 14.00% during the forecast period A team involved in preparing this...